These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2467138)

  • 21. Amlodipine versus atenolol in essential hypertension.
    Frishman WH; Brobyn R; Brown RD; Johnson BF; Reeves RL; Wombolt DG
    Am J Cardiol; 1994 Jan; 73(3):50A-54A. PubMed ID: 8310977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of early side effects with amlodipine and nifedipine retard in hypertension.
    Hosie J; Bremner AD; Fell PJ; James IG; Saul PA; Taylor SH
    Cardiology; 1992; 80 Suppl 1():54-9. PubMed ID: 1534716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of amlodipine and the nifedipine retard preparation in the treatment of arterial hypertension].
    Pivac N; Dobovisek J; Bagatin J; Gros Furek V; Rumboldt Z; Janezić A; Kveder R; Sjerobabski V; Simunić M; Sardelić S
    Lijec Vjesn; 1993; 115(11-12):356-9. PubMed ID: 8176999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension.
    Park S; Chung N; Kwon J; Yoon JH; Kim YJ; Han DS; Kim HS
    Clin Ther; 2005 Apr; 27(4):441-50. PubMed ID: 15922817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension.
    Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; Smit AJ
    Br J Clin Pharmacol; 2001 Dec; 52(6):687-92. PubMed ID: 11736880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of amlodipine on 24-hour ambulatory blood pressure in hypertensive patients.
    Mroczek WJ; Burris JF; Allenby KS
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S13-5. PubMed ID: 16296699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertension.
    Mehta JL; Lopez LM; Vlachakis ND; Gradman AH; Nash DT; O'Connell MT; Garland WT; Pickering BI
    Am Heart J; 1993 Jun; 125(6):1704-10. PubMed ID: 8498314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dose-response study of amlodipine in mild to moderate hypertension.
    Frick MH; McGibney D; Tyler HM
    J Intern Med; 1989 Feb; 225(2):101-5. PubMed ID: 2522134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
    Messerli F; Frishman WH; Elliott WJ
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Controlled study on the treatment of hypertension with verapamil in retard form].
    Belz GG; Spies G
    Z Kardiol; 1985 Aug; 74(8):453-9. PubMed ID: 3901562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study.
    Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Fluckiger L; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; van Roon AM; Smit AJ
    Am J Hypertens; 2001 Nov; 14(11 Pt 1):1083-9. PubMed ID: 11724204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy with amlodipine and captopril for resistant systemic hypertension.
    Maclean D
    Am J Cardiol; 1994 Jan; 73(3):55A-58A. PubMed ID: 8310978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial.
    Hong SJ; Ahn TH; Baek SH; Cho WH; Jeon HK; Kwan J; Yoon MH; Lee KJ; Lim DS
    Clin Ther; 2006 Apr; 28(4):537-51. PubMed ID: 16750465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
    Massie BM; Lacourcière Y; Viskoper R; Woittiez A; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):27C-33C. PubMed ID: 9286851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
    Fagan TC; Sternleib C; Vlachakis N; Deedwania PC; Mehta JL
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1109-13. PubMed ID: 6085377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.